Summary of Significant Accounting Policies - Summary of Revenue (Details) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Accounting Policies [Line Items]
Revenue		$ 766,554	$ 745,424	$ 550,700
Prescription Transactions Revenue
Accounting Policies [Line Items]
Revenue		550,536	593,359	488,257
Pharma Manufacturer Solutions Revenue
Accounting Policies [Line Items]
Revenue	[1]	99,425	73,348	20,488
Subscription Revenue
Accounting Policies [Line Items]
Revenue		96,167	59,925	29,386
Other Revenue
Accounting Policies [Line Items]
Revenue		$ 20,426	$ 18,792	$ 12,569

[1] Pharma manufacturer solutions revenue is presented separately from other revenue beginning in 2022. Prior period amounts have been recast to conform with the current period presentation.